Shire Wins Dismissal Of Adderall Antitrust Suit

A New York federal judge on Wednesday tossed a drug wholesaler's putative antitrust class action against Shire LLC for allegedly stifling generic competition for its blockbuster ADHD treatment Adderall XR, saying...

Already a subscriber? Click here to view full article